Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free ?-hCG and PAPP-A at 11 to 14 weeks

2003 ◽  
Vol 23 (4) ◽  
pp. 306-310 ◽  
Author(s):  
Simona Cicero ◽  
Renu Bindra ◽  
Georgios Rembouskos ◽  
Kevin Spencer ◽  
Kypros H. Nicolaides
Ultrasound ◽  
2008 ◽  
Vol 16 (4) ◽  
pp. 220-225 ◽  
Author(s):  
Debbie Nisbet

In some countries, measurement of nuchal translucency (NT) is incorporated into national antenatal screening programmes to help detect pregnancies at increased risk of Down syndrome. Accurate measurement of the NT requires a specific technique. This article is an illustrated practical guide outlining the steps required for measuring the NT; it provides useful tips for improving operator technique and advises how to avoid common pitfalls. Although fetal nasal bone assessment does not currently form part of official Down syndrome screening programmes (in Australia or the UK), it is included here as debate about its usefulness continues.


2005 ◽  
Vol 192 (4) ◽  
pp. 1107-1111 ◽  
Author(s):  
Francesco Orlandi ◽  
Cinzia Rossi ◽  
Emanuela Orlandi ◽  
Maria Cristina Jakil ◽  
Terrence W. Hallahan ◽  
...  

2007 ◽  
Vol 30 (4) ◽  
pp. 570-571
Author(s):  
W. Sepulveda ◽  
A. E. Wong ◽  
M. Loayza ◽  
V. Dezerega

2003 ◽  
Vol 21 (2) ◽  
pp. 156-160 ◽  
Author(s):  
V. Bunduki ◽  
R. Ruano ◽  
J. Miguelez ◽  
C. T. Yoshizaki ◽  
S. Kahhale ◽  
...  

2010 ◽  
Vol 36 (S1) ◽  
pp. 234-234
Author(s):  
K. Natasa ◽  
Z. Mikovic ◽  
M. Marinkovic ◽  
B. Damnjanovic-Pazin ◽  
Z. Milovanovic ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document